Product Code: ETC052464 | Publication Date: Jan 2021 | Updated Date: Apr 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The biologics market in Bahrain is a growing segment of the pharmaceutical industry, offering advanced treatments for various medical conditions, including cancer, autoimmune diseases, and genetic disorders. Biologics are complex drugs derived from living organisms and are used to treat diseases that cannot be addressed by traditional pharmaceuticals. As healthcare infrastructure in Bahrain improves and access to advanced medical treatments expands, the demand for biologics is rising. The market is expected to grow further as new biologic therapies are introduced and awareness of their benefits increases among healthcare professionals and patients.
The Bahrain biologics market is witnessing growth due to increasing demand for advanced therapies to treat chronic diseases, including cancer, autoimmune disorders, and infectious diseases. Biologics, which include vaccines, monoclonal antibodies, and gene therapies, offer targeted treatments with fewer side effects compared to traditional medications. The market is driven by advancements in biotechnology and an increasing number of clinical trials for new biologic therapies. Additionally, growing healthcare infrastructure and government support for biopharmaceutical research and development are contributing to the market`s expansion.
The biologics market in Bahrain is constrained by the countrys small healthcare industry and limited demand for advanced biopharmaceutical products. Biologics, which include treatments for chronic and complex diseases, are often expensive to produce and require specialized facilities for storage and administration. The high cost of importing biologics from international manufacturers further raises prices for consumers and healthcare providers. Additionally, regulatory challenges, such as the approval process for biologics, can delay their introduction to the market. The lack of local manufacturing capabilities for biologics further limits the markets growth potential in Bahrain.
The biologics market in Bahrain presents investment opportunities as the demand for advanced medical treatments continues to grow. Biologics, including vaccines, therapeutic proteins, and gene therapies, are used to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. Investors can focus on producing or distributing biologics, as well as establishing research and development facilities to meet the growing healthcare needs in Bahrain.
Bahrains biologics market is growing as advancements in biotechnology and pharmaceutical research continue to drive innovation in healthcare. Government policies aimed at improving access to cutting-edge medical treatments and supporting the development of biologics have contributed to the markets expansion. These policies focus on enhancing patient care through the adoption of advanced therapies and promoting local production of biologics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Biologics Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Biologics Market Revenues & Volume, 2024 & 2031F |
3.3 Bahrain Biologics Market - Industry Life Cycle |
3.4 Bahrain Biologics Market - Porter's Five Forces |
3.5 Bahrain Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Bahrain Biologics Market Revenues & Volume Share, By Product Type, 2024 & 2031F |
3.7 Bahrain Biologics Market Revenues & Volume Share, By Disease Category, 2024 & 2031F |
3.8 Bahrain Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2024 & 2031F |
4 Bahrain Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bahrain Biologics Market Trends |
6 Bahrain Biologics Market, By Types |
6.1 Bahrain Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Biologics Market Revenues & Volume, By Source, 2016 - 2031F |
6.1.3 Bahrain Biologics Market Revenues & Volume, By Microbial, 2016 - 2031F |
6.1.4 Bahrain Biologics Market Revenues & Volume, By Mammalian, 2016 - 2031F |
6.1.5 Bahrain Biologics Market Revenues & Volume, By Others, 2016 - 2031F |
6.2 Bahrain Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2016 - 2031F |
6.2.3 Bahrain Biologics Market Revenues & Volume, By Vaccines, 2016 - 2031F |
6.2.4 Bahrain Biologics Market Revenues & Volume, By Recombinant Proteins, 2016 - 2031F |
6.2.5 Bahrain Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2016 - 2031F |
6.2.6 Bahrain Biologics Market Revenues & Volume, By Others, 2016 - 2031F |
6.3 Bahrain Biologics Market, By Disease Category |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Biologics Market Revenues & Volume, By Oncology, 2016 - 2031F |
6.3.3 Bahrain Biologics Market Revenues & Volume, By Infectious Diseases, 2016 - 2031F |
6.3.4 Bahrain Biologics Market Revenues & Volume, By Immunological Disorders, 2016 - 2031F |
6.3.5 Bahrain Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2016 - 2031F |
6.3.6 Bahrain Biologics Market Revenues & Volume, By Hematological Disorders, 2016 - 2031F |
6.3.7 Bahrain Biologics Market Revenues & Volume, By Others, 2016 - 2031F |
6.4 Bahrain Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Biologics Market Revenues & Volume, By Outsourced, 2016 - 2031F |
6.4.3 Bahrain Biologics Market Revenues & Volume, By In-house, 2016 - 2031F |
7 Bahrain Biologics Market Import-Export Trade Statistics |
7.1 Bahrain Biologics Market Export to Major Countries |
7.2 Bahrain Biologics Market Imports from Major Countries |
8 Bahrain Biologics Market Key Performance Indicators |
9 Bahrain Biologics Market - Opportunity Assessment |
9.1 Bahrain Biologics Market Opportunity Assessment, By Source, 2024 & 2031F |
9.2 Bahrain Biologics Market Opportunity Assessment, By Product Type, 2024 & 2031F |
9.3 Bahrain Biologics Market Opportunity Assessment, By Disease Category, 2024 & 2031F |
9.4 Bahrain Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2024 & 2031F |
10 Bahrain Biologics Market - Competitive Landscape |
10.1 Bahrain Biologics Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |